
Alert: New Earnings Report (2/27/25)-Ligand Pharmaceuticals Inc (NASDAQ: LGND).
Ligand Pharmaceuticals Inc (NASDAQ: LGND) has reported E.P.S. of $-1.64 for its fourth fiscal quarter (ending December 31) versus $1.04 for the same period a year ago — a decline of -258%. For the latest […]